MagDI Australia Study
NCT: NCT06473831 · ACTIVE_NOT_RECRUITING
Brief Summary
The objective of the MagDI Australia Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).
Frequently Asked Questions
What is MagDI Australia Study?
MagDI Australia Study is a clinical trial registered under NCT06473831. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06473831?
The current status of NCT06473831 (MagDI Australia Study) is: ACTIVE_NOT_RECRUITING.
When did MagDI Australia Study start?
MagDI Australia Study started on 2024-08-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.